Dr. Daniel C. Lee, PhD, earned his doctorate degree in pharmaceutical sciences in neuropharmacology in 2005. His research focused on lysosomal proteases and protease inhibitor dysfunction in models of Parkinson's disease. He later received postdoctoral training in Alzheimer's disease, aging, and neuroinflammation at the University of South Florida (USF) Morsani College of Medicine and Byrd Alzheimer's Institute. He joined USF Taneja College of Pharmacy in 2010 as a founding faculty member and assistant professor in the Department of Pharmaceutical Sciences. He was later promoted to associate professor and Director of Neurodegenerative Science and W. Saunders Endowed Chair in Geriatric Pharmacotherapy in 2018.
Dr. Lee later relocated and joined the University of Kentucky College of Medicine Sanders-Brown Center on Aging and the school's Alzheimer's Disease Research Center in 2019 to study aging and multietiology dementias. His primary research focuses are arginine/polyamine metabolism, nutrient-sensing dysfunction, and post-translational modifications in proteinopathic disorders.